FDA Seeking Feedback on Patent And Care-Partner Connection

December 16, 2016

The FDA is asking for input on its new program, the Patient and Care-Partner Connection (P&CC), designed to allow CDRH staff to formally engage with patients and care partners to help develop, evaluate and monitor medical devices.

The P&CC will allow designated groups of patients and care partners to address specific questions about treatments, diagnoses and assessments by connecting patient organizations with CDRH staff.

The FDA has set a goal for 90 percent of CDRH employees to interact with patients as part of their job duties. It expects to meet the goal by the first quarter of next year. — Jeff Kinney

View today's stories